The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

Apogee plans to take a combination approach to AD by targeting Types 1-3 inflammation potentially offering JAK-like inhibition without their ...

The APG777 + APG990 coformulation has been shown to retain stability, injectability, and convenience of individual components. In preclinical studies it has demonstrated broad inhibition of Type 1, ...

A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found ...

An injection of a drug already on the market, Benralizamab, promises to be the next revolution in the treatment of asthma ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

Treatment for asthma and chronic obstructive pulmonary disease (COPD), which contributed to Sinead O'Connor's death last year ...

Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...

Asthma and chronic obstructive pulmonary disease (COPD) are significant health challenges, with asthma affecting around ...

A new study reveals benralizumab, an injectable drug, shows promise in reducing asthma and COPD flare-ups, outperforming traditional steroid treatments and minimizing side effects. The drug targets ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.